CuidAME: Longitudinal Data Collection From Patients With Spinal Muscular Atrophy in Spain
NCT07231549 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-11-17
Summary
The goal of this observational study is to set up a longitudinal data collection study to perform a long-term follow-up of SMA patients in a real-world setting, and to standardise and homogenize the data collection process for SMA patient's data.
Treated and untreated patients will be followed based on the routine clinical practice schedule.
Conditions
Sponsors & Collaborators
-
Fundació Sant Joan de Déu
lead OTHER
Principal Investigators
-
Andrés Nascimento · Hospital Sant Joan de Deu
-
Mónica Povedano Panadés · Hospital Universitari de Bellvitge
-
Francina Munell Casadesús · Hospital Universitari Vall d'Hebrón
-
Miguel Angel Fernández García Miguel Angel Fernández García · Hospital Universitario La Paz
-
Inmaculada Pitarch Castellano · Hospital Universitario La Fe
-
Juan Francisco Vázquez Costa · Hospital Universitario La Fe
-
Maria Grazia Cattinari · Fundación Atrofia Muscular Espinal
-
Rocío Calvo · Hospital Universitario Regional de Málaga
-
Eduardo Martínez Salcedo · Hospital Universitario Virgen de la Arrixaca
-
Antonio Moreno Escribano · Hospital Universitario Virgen de la Arrixaca
-
Julita Medina Cantillo · Hospital Sant Joan de Deu
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-05
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
NCT04295538 ·Status: COMPLETED ·Phase: PHASE2
-
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT07154524 ·Status: RECRUITING
-
Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
NCT06877403 ·Status: ENROLLING_BY_INVITATION
-
An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT07188844 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
NCT05295433 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04529291 ·Status: WITHDRAWN ·Phase: NA
-
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
NCT05136976 ·Status: RECRUITING ·Phase: PHASE3
-
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
NCT07337785 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Adult Autoimmune Myopathies (MAIA)
NCT04792931 ·Status: RECRUITING ·Phase: NA
-
Predictive Factors of Long Term Outcome in MMN
NCT04015934 ·Status: COMPLETED
-
Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT02629796 ·Status: COMPLETED
-
Study of CIDP Patients During IVIG Treatment
NCT00305266 ·Status: COMPLETED
-
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
NCT03751644 ·Status: COMPLETED ·Phase: NA
-
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
NCT07264426 ·Status: RECRUITING
-
The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies
NCT03864185 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
NCT02892890 ·Status: COMPLETED ·Phase: NA
-
Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis
NCT02816476 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
NCT01183598 ·Status: COMPLETED ·Phase: PHASE1
-
AL Amyloidosis and Anti-CD38-Daratunumab
NCT06571864 ·Status: COMPLETED ·Phase: NA
-
Collection of Biological Samples From Patients With Rare Neurological Diseases
NCT04698421 ·Status: RECRUITING
-
Immune Abnormalities in Sporadic Inclusion Body Myositis
NCT00030212 ·Status: COMPLETED
-
the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
NCT07339540 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Sporadic Inclusion Body Myositis Natural History Study
NCT05046821 ·Status: ACTIVE_NOT_RECRUITING
-
Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis
NCT07039578 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
NCT04561557 ·Status: RECRUITING ·Phase: EARLY_PHASE1